Title : Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.

Pub. Date : 2018 Apr 10

PMID : 29373839






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. Paclitaxel NUS1 dehydrodolichyl diphosphate synthase subunit Homo sapiens
2 Here, we demonstrate NgBR as a potential therapeutic target for ERalpha positive breast cancer patients to attenuate paclitaxel resistance. Paclitaxel NUS1 dehydrodolichyl diphosphate synthase subunit Homo sapiens
3 NgBR knockdown enhanced paclitaxel-induced cell apoptosis by modulating expression of p53 and survivin in ERalpha positive breast cancer cells via NgBR-mediated PI3K/Akt and MAPK/ERK signaling pathways. Paclitaxel NUS1 dehydrodolichyl diphosphate synthase subunit Homo sapiens
4 NgBR knockdown enhanced paclitaxel-induced cell apoptosis by modulating expression of p53 and survivin in ERalpha positive breast cancer cells via NgBR-mediated PI3K/Akt and MAPK/ERK signaling pathways. Paclitaxel NUS1 dehydrodolichyl diphosphate synthase subunit Homo sapiens
5 In summary, our data suggest that NgBR expression is essential to promoting ERalpha positive breast cancer cell resistance to paclitaxel. Paclitaxel NUS1 dehydrodolichyl diphosphate synthase subunit Homo sapiens